Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Acridine orange

  • You have access
    Impact of Acridine Orange in Patients With Local Recurrent Soft Tissue Sarcoma
    HIROYUKI TSUCHIE, MAKOTO EMORI, NAOHISA MIYAKOSHI, KYOJI OKADA, HIROYUKI NAGASAWA, YASUTAKA MURAHASHI, EMI MIZUSHIMA, JUNYA SHIMIZU, TOSHIHIKO YAMASHITA and YOICHI SHIMADA
    In Vivo September 2020, 34 (5) 2745-2750; DOI: https://doi.org/10.21873/invivo.12097
  • You have access
    Determination of the LD50 of Acridine Orange via Intravenous Administration in Mice in Preparation for Clinical Application to Cancer Therapy
    TOMOKI NAKAMURA, KATSUYUKI KUSUZAKI, TAKAO MATSUBARA, AKIHIKO MATSUMINE, KUNIHIRO ASANUMA, HARUHIKO SATONAKA, ATSUMASA UCHIDA and AKIHIRO SUDO
    In Vivo July 2014, 28 (4) 523-527;
In Vivo

© 2022 In Vivo

Powered by HighWire